<DOC>
	<DOCNO>NCT00037804</DOCNO>
	<brief_summary>Drugs use chemotherapy u different way stop tumor cell divide stop grow die . Irinotecan may effective treat patient refractory solid tumor liver dysfunction .</brief_summary>
	<brief_title>Irinotecan Treating Patients With Refractory Solid Tumors Liver Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<criteria>Other specific inclusion/exclusion criterion may apply . In order determine eligibility , examination investigator necessary . Histological proof malignant solid tumor refractory standard form therapy know curative therapy exist ; Measurable evaluable disease ; At least 6 week since prior chemotherapy nitrosoureas ; At least 28 day since prior anticancer therapy recover ; At least 4 week since prior radiation therapy recover ; Age 18 year old ; SWOG 02 ; Life expectancy least 12 week ; Segmented neutrophils band least 1,500/mm3 ; Hemoglobin least 9.0 g/dL platelet count least 100,000/mm3 ; Prothrombin time partial thromboplastin time great 2.0 time control ; INR great 3.0 time control ; Concurrent use coumadin allow dose stable prothrombin time INR stable ; Total serum bilirubin least 1.5 great 5.0 time upper limit normal ; SGOT/SGPT great 5 time upper limit normal ; SGOT/SGPT least 1.5 great 20.0 time upper limit normal ; Creatinine great 2 Patients express tumor marker evidence disease previously irradiate area increase size ; Prior chemotherapy treatment irinotecan mitomycin ; Prior abdominal and/or pelvic radiation therapy ; Current history hepatitis B infection positive test hepatitis B surface antigen ; Hepatic encephalopathy include somnolence , confusion , asterixis ; History myocardial infarction within 6 month history congestive heart failure ( CHF ) ; clinical evidence CHF ; Evidence arrhythmia patient history cardiac arrhythmia ; Uncontrolled hypertension , unstable angina , active CHF , serious uncontrolled cardiac arrhythmia ; Interstitial pneumonia fibroid lung ( patient must large pleural effusion drain sclerosed control prior study ; patient must clinically apparent ascites drain prior irinotecan treatment ) ; CNS metastases carcinomatous meningitis ; Concurrent use anticonvulsant ; Active uncontrolled</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Pharmacia</keyword>
</DOC>